Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 103 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic CancerCompletedNCT00369889Phase 2
- A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLCTerminatedNCT00369070Phase 2
- Study Evaluating HKI-272 Administered to Healthy SubjectsCompletedNCT00366600Phase 1
- Study of XL647 in Subjects With Non-Small-Cell Lung CancerCompletedNCT00364780Phase 2
- A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer PatientsCompletedNCT00363194Phase 1
- SU011248 in Advanced Hepatocellular CarcinomaCompletedNCT00361309Phase 2
- SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerTerminatedNCT00361244Phase 1/2
- An Open Label Treatment Extension Study of AMG 706TerminatedNCT00360867Phase 2
- Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaStatus unknownNCT00360854Phase 1
- Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast CancerCompletedNCT00359190Phase 1
- The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular EdemaTerminatedNCT00358423Phase 1/2
- Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034CompletedNCT00358384Phase 1
- Trial of PTK787/ZK 222584 Plus PaclitaxelTerminatedNCT00358163Phase 1
- Bevacizumab and Sunitinib in Treating Patients With Solid TumorsCompletedNCT00357318Phase 1
- A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast CancerTerminatedNCT00356681Phase 2
- Vascular and Skeletal Protective Effects of Genistein in Postmenopausal WomenCompletedNCT00355953Phase 2/3
- Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNCT00354549Phase 2
- Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaTerminatedNCT00354523Phase 1/2
- A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMDStatus unknownNCT00354445Phase 4
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaCompletedNCT00354068Phase 1
- Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic LeukemiaCompletedNCT00352677Phase 1
- BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerTerminatedNCT00352079Phase 3
- Study of XL820 Given Orally Daily to Subjects With Solid TumorsCompletedNCT00350831Phase 1
- Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLWithdrawnNCT00349518Phase 2/3
- TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
- Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaCompletedNCT00349206Phase 1
- Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in DiabeticsTerminatedNCT00346983Phase 1/2
- Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00345826Phase 1
- Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted TherapyWithdrawnNCT00343759Phase 2
- First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR GeneStatus unknownNCT00339586Phase 2
- A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)CompletedNCT00337883Phase 2
- Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in JapanCompletedNCT00337454Phase 1/2
- Study of XL647 Administered Orally Daily to Patients With Solid TumorsCompletedNCT00336765Phase 1
- Sunitinib Malate With Hormonal Ablation for Patients Who Will Have ProstatectomyActive, not recruitingNCT00329043Phase 2
- A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT00329004Phase 1
- Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic PhaseStatus unknownNCT00327262Phase 3
- AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS TumorsCompletedNCT00326664Phase 1
- Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)CompletedNCT00326339Phase 2
- Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00323791Phase 2
- Study of XL999 in Patients With Acute Myeloid Leukemia (AML)TerminatedNCT00322673Phase 2
- A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.CompletedNCT00321997Phase 2/3
- Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung CancerCompletedNCT00321815Phase 2
- AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00321724Phase 2
- AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous LeukemiaCompletedNCT00321581Phase 1
- Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00320073Phase 1
- Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCStatus unknownNCT00319800Phase 2
- Combination Casodex® and Iressa™ in Locally Advanced Prostate CancerCompletedNCT00319787Phase 2
- Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian CancerTerminatedNCT00317434Phase 1
- Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib MesylateCompletedNCT00316953Phase 1
- Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast CancerCompletedNCT00316875Phase 1
- Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer PatientsCompletedNCT00316407Phase 1/2
- Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic CarcinomaCompletedNCT00314873Phase 1
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)TerminatedNCT00312351Phase 4
- Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
- AZD2171 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00305656Phase 2
- Study of XL999 in Patients With Multiple MyelomaTerminatedNCT00304590Phase 2
- A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic MelanomaCompletedNCT00304525Phase 1/2
- Temodar and Sutent as Therapy for MelanomaTerminatedNCT00304200Phase 1/2
- Sorafenib and Bortezomib in Treating Patients With Advanced CancerCompletedNCT00303797Phase 1
- Vatalanib and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00303732Phase 1
- Safety of TKI258 in Advanced/Metastatic Melanoma SubjectsCompletedNCT00303251Phase 1/2
- ARQ 197 in Subjects With Metastatic Solid TumorsCompletedNCT00302172Phase 1
- Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00301847Phase 2
- Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00301093Phase 1
- IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00300586Phase 3
- Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) MalignanciesTerminatedNCT00300027Phase 1
- Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast CancerCompletedNCT00299286Phase 2
- A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib MesylateCompletedNCT00298987Phase 2
- A Study of IRESSA in Relapsed and Refractory Small Cell Lung CancerCompletedNCT00298688Phase 2
- A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction TherapyWithdrawnNCT00297921Phase 1/2
- Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib TherapyStatus unknownNCT00297570Phase 3
- Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon CancerStatus unknownNCT00295035Phase 3
- A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy RegimensCompletedNCT00294736Phase 1
- Celecoxib and Erlotinib in Treating Patients With Liver CancerWithdrawnNCT00293436Phase 1/2
- Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNCT00293371Phase 1/2
- Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal TumorsCompletedNCT00293124Phase 3
- Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryTerminatedNCT00290719Phase 1
- Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)Status unknownNCT00290485Phase 2
- Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisCompletedNCT00287846Phase 1/2
- BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's SarcomaTerminatedNCT00287495Phase 1
- Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00287105Phase 2
- A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung CancerTerminatedNCT00283634Phase 2
- Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular CarcinomaStatus unknownNCT00282100Phase 2
- Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic CancerTerminatedNCT00281996Phase 1
- Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck CancerCompletedNCT00281866Phase 2
- Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid LeukemiaTerminatedNCT00279773Phase 1
- A Study of ARRY-334543 in Patients With Advanced CancerCompletedNCT00278902Phase 1
- Sorafenib in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00278382Phase 2
- Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00278187Phase 2
- Study of XL999 in Patients With Non-small Cell Lung CancerTerminatedNCT00277329Phase 2
- Study of XL999 in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00277316Phase 2
- Study of XL999 in Patients With Metastatic Colorectal CancerTerminatedNCT00277303Phase 2
- Study of XL999 in Patients With Previously Treated Ovarian CancerTerminatedNCT00277290Phase 2
- Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic LeukemiasStatus unknownNCT00276926Phase 2
- Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerCompletedNCT00276835Early Phase 1
- Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid TumorsCompletedNCT00276575Phase 1
- Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00275132Phase 3
- Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00274833Phase 2
- MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous LeukemiaCompletedNCT00274248Phase 1